Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02349542).
- Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03663283).
- Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA): Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02197273).
- Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02219087).
- Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Liposomal Bupivacaine vs Dexamethasone ISB: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine vs Dexamethasone ISB: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04047446).
- Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- LIPSIndependent statistical analysis of A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LIPS-A: Lung Injury Prevention Study With Aspirin: Complete Statistical AnalysisIndependent statistical analysis of LIPS-A: Lung Injury Prevention Study With Aspirin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01504867).
- LiquID Guide Catheter Extension Safety Study: Complete Statistical AnalysisIndependent statistical analysis of LiquID Guide Catheter Extension Safety Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05406596).
- Liraglutide in the Treatment of Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Liraglutide in the Treatment of Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01722266).
- Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting: Complete Statistical AnalysisIndependent statistical analysis of Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755416).
- LIREIndependent statistical analysis of Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02015455).
- Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab: Complete Statistical AnalysisIndependent statistical analysis of Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LITEIndependent statistical analysis of Low InTensity Exercise Intervention in PAD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02538900).
- Lithium Disilicate (CAD/CAM) Fixed Partial Dentures (FPD) Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Lithium Disilicate (CAD/CAM) Fixed Partial Dentures (FPD) Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03036566).
- LiTMUSIndependent statistical analysis of Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Litramine in Weight Maintenance: Complete Statistical AnalysisIndependent statistical analysis of Litramine in Weight Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01505387).
- LITROSIndependent statistical analysis of Lifestyle Intervention and Testosterone Replacement in Obese Seniors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02367105).
- Little Cigar and Cigarillo Warnings for Youth: Complete Statistical AnalysisIndependent statistical analysis of Little Cigar and Cigarillo Warnings for Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06413797).
- Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults: Complete Statistical AnalysisIndependent statistical analysis of Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LiveWellIndependent statistical analysis of DBT for Metastatic Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04973436).
- LIVIINIndependent statistical analysis of Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Living Well Project for Persons With AIDS: Complete Statistical AnalysisIndependent statistical analysis of Living Well Project for Persons With AIDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01848483).
- Living With Multimorbidity: CO-ORDINATE Program: Complete Statistical AnalysisIndependent statistical analysis of Living With Multimorbidity: CO-ORDINATE Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05985044).
- LixiLan-DIndependent statistical analysis of Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents: primary endpoint results,…
- LLTEVARIndependent statistical analysis of LSA Reconstruction With Laser Fenestration During the TEVAR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03845829).
- Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Local Phase 4 Pan-European SMART Study: Complete Statistical AnalysisIndependent statistical analysis of Local Phase 4 Pan-European SMART Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00463866).
- LOCALIZEIndependent statistical analysis of Electrical Coupling Information From The Rhythmia HDx System And DirectSense Technology In Subjects With Paroxysmal Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Location Initiated Individualized Texts for Adolescent Health (LIITAH): Complete Statistical AnalysisIndependent statistical analysis of Location Initiated Individualized Texts for Adolescent Health (LIITAH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03762135).
- Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment: Complete Statistical AnalysisIndependent statistical analysis of Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04056182).
- LOGICIndependent statistical analysis of LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LoGoIndependent statistical analysis of Low-dose Gonal-f® in Ovulation Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01871532).
- LOGRIBMETIndependent statistical analysis of Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes – a Randomized Pragmatic Trial: Complete Statistical AnalysisIndependent statistical analysis of Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial:…
- Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg): Complete Statistical AnalysisIndependent statistical analysis of Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen…
- Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial: primary endpoint results,…
- Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study: Complete Statistical AnalysisIndependent statistical analysis of Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study: primary endpoint results, effect estimate…
- Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long Term Safety Assessment of SER120 in Patients With Nocturia: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety Assessment of SER120 in Patients With Nocturia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00981682).
- Long Term Safety Observation of Crizotinib in Chinese NSCLC Population: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety Observation of Crizotinib in Chinese NSCLC Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03672643).
- Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…